'Black Box Warning' Counters Levaquin Claims, Judge Says

Law360, New York (June 21, 2013, 4:00 PM EDT) -- Johnson & Johnson adequately warned a Levaquin user that the antibiotic is linked to tendon tears, a New Jersey judge ruled, rejecting the man's contention that a so-called black box warning failed because it did not compare Levaquin's risks to those of similar drugs.

Judge Carol Higbee granted summary judgment to Johnson & Johnson on June 17 in a suit in multicounty litigation over tendon injuries allegedly caused by Levaquin. The drugmaker is also facing federal multidistrict litigation in Minnesota over the claims, although a substantial...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.